CBAK ENERGY TECHNOLOGY INC (CBAT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CBAT • US14986C1027

0.7951 USD
+0.01 (+0.66%)
At close: Feb 5, 2026
0.78 USD
-0.02 (-1.9%)
After Hours: 2/5/2026, 8:12:55 PM
Fundamental Rating

3

Taking everything into account, CBAT scores 3 out of 10 in our fundamental rating. CBAT was compared to 91 industry peers in the Electrical Equipment industry. Both the profitability and financial health of CBAT have multiple concerns. While showing a medium growth rate, CBAT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • CBAT had negative earnings in the past year.
  • In the past year CBAT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CBAT reported negative net income in multiple years.
  • In multiple years CBAT reported negative operating cash flow during the last 5 years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

  • With a decent Return On Assets value of -1.79%, CBAT is doing good in the industry, outperforming 62.64% of the companies in the same industry.
  • CBAT's Return On Equity of -5.36% is fine compared to the rest of the industry. CBAT outperforms 63.74% of its industry peers.
Industry RankSector Rank
ROA -1.79%
ROE -5.36%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

  • CBAT's Profit Margin has declined in the last couple of years.
  • CBAT's Gross Margin of 14.07% is on the low side compared to the rest of the industry. CBAT is outperformed by 63.74% of its industry peers.
  • CBAT's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CBAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • CBAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CBAT has about the same amount of shares outstanding.
  • The number of shares outstanding for CBAT has been increased compared to 5 years ago.
  • The debt/assets ratio for CBAT has been reduced compared to a year ago.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -0.19, we must say that CBAT is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CBAT (-0.19) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.29 indicates that CBAT is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.29, CBAT is in the better half of the industry, outperforming 60.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z -0.19
ROIC/WACCN/A
WACC5.61%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • CBAT has a Current Ratio of 0.69. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CBAT has a worse Current ratio (0.69) than 82.42% of its industry peers.
  • CBAT has a Quick Ratio of 0.69. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of CBAT (0.54) is worse than 78.02% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.54
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • CBAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -141.18%.
  • CBAT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -42.83% yearly.
  • The Revenue for CBAT has decreased by -22.02% in the past year. This is quite bad
  • CBAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.40% yearly.
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%

3.2 Future

  • Based on estimates for the next years, CBAT will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.42% on average per year.
  • CBAT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.48% yearly.
EPS Next Y-139.23%
EPS Next 2Y-11.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.19%
Revenue Next 2Y30.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.05 -0.05 0.1 0.15

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • CBAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 7.80, the valuation of CBAT can be described as very cheap.
  • CBAT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CBAT is cheaper than 96.70% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. CBAT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.8
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • CBAT's earnings are expected to decrease with -11.42% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.42%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CBAT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (2/5/2026, 8:12:55 PM)

After market: 0.78 -0.02 (-1.9%)

0.7951

+0.01 (+0.66%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-10
Earnings (Next)03-16
Inst Owners2.7%
Inst Owner Change-0.08%
Ins Owners5.56%
Ins Owner Change0%
Market Cap70.49M
Revenue(TTM)161.76M
Net Income(TTM)-6.51M
Analysts0
Price Target1.53 (92.43%)
Short Float %0.2%
Short Ratio1.19
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)26.47%
Max EPS beat(2)173.53%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)35.26%
Min Revenue beat(2)18.4%
Max Revenue beat(2)52.11%
Revenue beat(4)2
Avg Revenue beat(4)-3.55%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)52.11%
Revenue beat(8)2
Avg Revenue beat(8)-9.8%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)58.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)53.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)28.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.8
P/S 0.44
P/FCF N/A
P/OCF 2.48
P/B 0.58
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)0.1
Fwd EY12.83%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.32
OCFY40.36%
SpS1.82
BVpS1.37
TBVpS1.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.79%
ROE -5.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.07%
FCFM N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 509.98%
Cap/Sales 22.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.54
Altman-Z -0.19
F-Score2
WACC5.61%
ROIC/WACCN/A
Cap/Depr(3y)245.38%
Cap/Depr(5y)296.85%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-139.23%
EPS Next 2Y-11.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.02%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%
Revenue Next Year-0.19%
Revenue Next 2Y30.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-149.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.57%
OCF growth 3YN/A
OCF growth 5YN/A

CBAK ENERGY TECHNOLOGY INC / CBAT FAQ

What is the fundamental rating for CBAT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CBAT.


What is the valuation status of CBAK ENERGY TECHNOLOGY INC (CBAT) stock?

ChartMill assigns a valuation rating of 2 / 10 to CBAK ENERGY TECHNOLOGY INC (CBAT). This can be considered as Overvalued.


How profitable is CBAK ENERGY TECHNOLOGY INC (CBAT) stock?

CBAK ENERGY TECHNOLOGY INC (CBAT) has a profitability rating of 2 / 10.


Can you provide the financial health for CBAT stock?

The financial health rating of CBAK ENERGY TECHNOLOGY INC (CBAT) is 2 / 10.